Presentation by: Peter A. Kreckel, R.Ph
Location: Nickman's Drug, Lemont Furnace, PA
Compare and contrast different types of insurance available.
Describe necessary numbers to process prescriptions on a patient’s insurance.
Define key terms such as:
AWP (Average Wholesale Price)
WAC (Wholesale Acquisition Cost)
Prior Authorization
Formularies
DIR Fees (Direct/Indirect Remuneration Fees)
List tiers of medications and examples in each tier.
Founded: 1966, single-payer national social insurance program.
Administration: Contracted with approximately 30-50 private insurance companies.
Funding Sources:
Payroll tax
Premiums and surtaxes from beneficiaries
General revenue
Eligibility:
Primarily for Americans aged 65+.
Coverage for certain younger individuals with disabilities.
National Health Expenditure (NHE) in 2020 was $4.1 trillion, accounting for 19.7% of GDP, with significant increases projected.
Enrollment projected to exceed 80 million by 2030 with a decline in workers per enrollee from 3.7 to 2.4.
Part A: Hospital Insurance (covers inpatient care)
Part B: Medical Insurance (outpatient care and physician services)
Part C: Medicare Advantage (private plans providing Medicare benefits)
Part D: Drug Coverage (prescription medications)
Part B Premium: Standard rate of $174.70 in 2024, increasing based on income.
Cost Sharing:
Part A deductible: $1,632 per benefit period (2024).
Part B deductible: $224 annually (2024).
Medicare typically covers 80% of health care costs; patients often need supplemental insurance to cover the remaining 20% (Medigap policies).
Enrollment in Medigap at age 65 is advisable to avoid health underwriting.
Differences: Must provide at least the same coverage as Original Medicare (Parts A & B), often with additional benefits.
Premiums can be as low as $0 but may include additional out-of-pocket costs.
Important to consider deductibles and out-of-network charges.
Enrollment periods allow switching between plans.
Description: A program for low-income individuals and those with disabilities, providing assistance that can overlap with Medicare for 'dual-eligible' individuals.
Eligibility in West Virginia: Covers SSI beneficiaries, pregnant women, children under 19, low-income families, and individuals with specific health conditions.
Originated in the 1870s with hospital associations; expanded significantly by the 1930s.
Insurance companies collect premiums to cover enrollees' healthcare costs while ensuring a balance of healthy individuals to maintain affordability.
Major PBMs like CVS-Caremark manage formularies, negotiate pricing, and adjudicate claims.
Aim to maintain or reduce pharmacy costs while improving health outcomes.
BIN Number: For routing electronic pharmacy claims.
PCN Number: Secondary identifier for differentiating plans.
Group Number: Identifies specific health plan groups.
ID Number: Specific to the individual patient, previously based on SSN.
Refers to average selling price of pharmaceuticals, currently noted as WAC + 20%.
Examples provided demonstrate significant variability in discounts offered for generics vs brand names.
WAC: Manufacturer's list price to wholesalers, exclusive of discounts/rebates.
NADAC and ACA-WAMP provide averages relevant for retail pharmacies.
Purpose: Assess medication therapy before dispensing, ensuring safety and efficacy.
Types of DUR include prospective evaluations and concurrent reviews for safe medication use.
Open Formulary: No medication access limitations.
Closed Formulary: Limited access based on cost and other criteria.
Example: Specific preferred meds for certain health conditions.
Tier 1: Generic medications (most affordable).
Tier 2: Preferred brand-name drugs.
Tier 3: Non-preferred brand-name medications.
Tier 4: Specialty drugs with higher costs.
Tier 1: Lisinopril, Metformin.
Tier 2: Janumet, Invokana.
Tier 3: Farxiga, Symbicort.
Tier 4: Specialty drugs for chronic conditions.
Some medications, particularly for opioids and psychiatry, require prior authorization based on usage guidelines.
Processes for overrides and monitoring handled within pharmacy operations.
Overview of how DIR fees impact pharmacy revenue and operations. Significant increases noted over the past decade, with current trends indicating a move towards greater expense burdens on pharmacies.
The evolving landscape of healthcare reimbursement affects community pharmacies significantly, emphasizing the importance of understanding these structures for effective patient care.